Evidence map›Paper›PMID 25411244›Full record

ArticleThe Journal of biological chemistry2015

Crystal structure of snake venom acetylcholinesterase in complex with inhibitory antibody fragment Fab410 bound at the peripheral site: evidence for open and closed states of a back door channel.

Yves Bourne, Ludovic Renault, Pascale Marchot

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Acetylcholinesterase: Structure, dynamics, and interactions with organophosphorus compounds.Protein science : a publication of the Protein Society · 2025
    Review
  3. Selective blockade of CaNature communications · 2024
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. A Second Look at the Crystal Structures ofMolecules (Basel, Switzerland) · 2020
    Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Computational Studies on Acetylcholinesterases.Molecules (Basel, Switzerland) · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Yves BourneFrom Aix-Marseille Université, Architecture et Fonction des Macromolécules Biologiques, campus Luminy, 13228 Marseille cedex 09, France, CNRS, Architecture et Fonction des Macromolécules Biologiques, campus Luminy, 13228 Marseille cedex 09, France, and.
Ludovic RenaultCNRS/Aix-Marseille Université, Ingénierie des Protéines, Faculté de Médecine-Secteur Nord, 13344 Marseille cedex 15, France.
Pascale MarchotFrom Aix-Marseille Université, Architecture et Fonction des Macromolécules Biologiques, campus Luminy, 13228 Marseille cedex 09, France, CNRS, Architecture et Fonction des Macromolécules Biologiques, campus Luminy, 13228 Marseille cedex 09, France, and CNRS/Aix-Marseille Université, Ingénierie des Protéines, Faculté de Médecine-Secteur Nord, 13344 Marseille cedex 15, France pascale.marchot@univ-amu.fr.
Centre National de la Recherche Scientifique · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The acetylcholinesterase found in the venom of Bungarus fasciatus (BfAChE) is produced as a soluble, non-amphiphilic monomer with a canonical catalytic domain but a distinct C terminus compared with the other vertebrate enzymes. Moreover, the peripheral anionic site of BfAChE, a surface site located at the active site gorge entrance, bears two substitutions altering sensitivity to cationic inhibitors. Antibody Elec410, generated against Electrophorus electricus acetylcholinesterase (EeAChE), inhibits EeAChE and BfAChE by binding to their peripheral sites. However, both complexes retain significant residual catalytic activity, suggesting incomplete gorge occlusion by bound antibody and/or high frequency back door opening. To explore a novel acetylcholinesterase species, ascertain the molecular bases of inhibition by Elec410, and document the determinants and mechanisms for back door opening, we solved a 2.7-Å resolution crystal structure of natural BfAChE in complex with antibody fragment Fab410. Crystalline BfAChE forms the canonical dimer found in all acetylcholinesterase structures. Equally represented open and closed states of a back door channel, associated with alternate positions of a tyrosine phenol ring at the active site base, coexist in each subunit. At the BfAChE molecular surface, Fab410 is seated on the long Ω-loop between two N-glycan chains and partially occludes the gorge entrance, a position that fully reflects the available mutagenesis and biochemical data. Experimentally based flexible molecular docking supports a similar Fab410 binding mode onto the EeAChE antigen. These data document the molecular and dynamic peculiarities of BfAChE with high frequency back door opening, and the mode of action of Elec410 as one of the largest peptidic inhibitors targeting the acetylcholinesterase peripheral site.

Indexed as

AcetylcholinesteraseAmino Acid SequenceAntibodies, MonoclonalAntigensCatalysisCatalytic DomainCholinesterase InhibitorsCrystallography, X-RayHumansImmunoglobulin FragmentsMolecular Sequence DataPhenolPolysaccharidesProtein BindingProtein ConformationProtein MultimerizationAcetylcholinesteraseAntibodies, MonoclonalAntigensCholinesterase InhibitorsImmunoglobulin FragmentsPhenolPolysaccharidesSnake VenomsSolventsAcetylcholinesterase (AChE)Back Door ChannelEnzyme MechanismHomology ModelingMonoclonal AntibodyPeripheral Anionic SiteRegulation of CatalysisSnake VenomX-ray Crystallography

Identifiers

PMID25411244
PMCPMC4340399
OpenAlexW2088085988

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.